bisoprolol fumarate and hydrochlorothiazide
Generic: bisoprolol fumarate and hydrochlorothiazide
Labeler: edenbridge pharmaceuticals llc.Drug Facts
Product Profile
Brand Name
bisoprolol fumarate and hydrochlorothiazide
Generic Name
bisoprolol fumarate and hydrochlorothiazide
Labeler
edenbridge pharmaceuticals llc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
bisoprolol fumarate 2.5 mg/1, hydrochlorothiazide 6.25 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42799-920
Product ID
42799-920_46410e5f-f09f-62ff-e063-6394a90afdda
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212678
Listing Expiration
2026-12-31
Marketing Start
2019-04-30
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42799920
Hyphenated Format
42799-920
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bisoprolol fumarate and hydrochlorothiazide (source: ndc)
Generic Name
bisoprolol fumarate and hydrochlorothiazide (source: ndc)
Application Number
ANDA212678 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2.5 mg/1
- 6.25 mg/1
Packaging
- 100 TABLET, FILM COATED in 1 BOTTLE (42799-920-01)
- 500 TABLET, FILM COATED in 1 BOTTLE (42799-920-02)
- 30 TABLET, FILM COATED in 1 BOTTLE (42799-920-30)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46410e5f-f09f-62ff-e063-6394a90afdda", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0342799922300", "0342799921020", "0342799921013", "0342799921303", "0342799920306", "0342799922027", "0342799920016", "0342799920023"], "unii": ["0J48LPH2TH", "UR59KN573L"], "rxcui": ["854908", "854916", "854919"], "spl_set_id": ["295532b5-65c8-40c3-8d27-cfd334d12802"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Edenbridge Pharmaceuticals LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (42799-920-01)", "package_ndc": "42799-920-01", "marketing_start_date": "20190430"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (42799-920-02)", "package_ndc": "42799-920-02", "marketing_start_date": "20190430"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (42799-920-30)", "package_ndc": "42799-920-30", "marketing_start_date": "20190430"}], "brand_name": "Bisoprolol Fumarate and Hydrochlorothiazide", "product_id": "42799-920_46410e5f-f09f-62ff-e063-6394a90afdda", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "42799-920", "generic_name": "Bisoprolol Fumarate and Hydrochlorothiazide", "labeler_name": "Edenbridge Pharmaceuticals LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bisoprolol Fumarate and Hydrochlorothiazide", "active_ingredients": [{"name": "BISOPROLOL FUMARATE", "strength": "2.5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "6.25 mg/1"}], "application_number": "ANDA212678", "marketing_category": "ANDA", "marketing_start_date": "20190430", "listing_expiration_date": "20261231"}